Sun Pharma launches Leqselvi for treatment of severe alopecia areata
With limited treatment options available to people living with severe alopecia areata in the U.S., the need for innovative therapies such as Leqselvi remains critically important.
Pharmacy
Cardinal Health announces One Voice Initiative to support independent pharmacy advocacy
This investment furthers Cardinal Health's longstanding advocacy around the future of independent pharmacies and ongoing partnerships with industry organizations to support pharmacists' efforts to build relationships with elected officials at all levels of government.
NCPA: PBM Reform Act must pass ASAP
Systemic changes like those in the PBM Reform Act must pass and be enacted as soon as possible. We’re grateful for this bill’s introduction and will do everything we can to push it across the finish line.”
NACDS hails introduction of Pharmacy Benefit Manager Reform Act of 2025
The bill establishes powerful transparency requirements, bans spread pricing, assures fair reimbursement for pharmacies, and tackles anti-competitive practices that have driven up drug costs and limited patient choice.
Patent thickets and litigation abuses hinder all biosimilars
White paper analyzes problems and solutions to patent abuses.
Clover Health launches New Jersey Community Pharmacy Program in partnership with IPC’s iCare+ Network
The program will be anchored by IPC’s iCare+ Independent Pharmacy Network, which includes thousands of community-rooted pharmacies nationwide and many in New Jersey.
Merck to acquire Verona Pharma, expanding its portfolio to include Ohtuvayre
Acquisition aligns with Merck’s science-led business development strategy and expands pipeline and portfolio of treatments for cardio-pulmonary diseases.
Lupin launches ipratropium bromide nasal solution
Ipratropium bromide nasal solution (Nasal Spray), 0.03% and 0.06% are bioequivalent to Atrovent Nasal Spray, 0.03% and 0.06%, of Boehringer Ingelheim Pharmaceuticals.
Judge orders CVS’ Omnicare unit to pay $949M in fraud case
"This lawsuit centered on a highly technical prescription dispensing record keeping issue that was allowed by law in many states," CVS said in a statement.
Groups join the Biosimilars Council and AAM letter of support for interchangeability legislation
39 Groups support the Biosimilar Red Tape Elimination Act.
Major insurance change hits users of Zepbound for weight loss
Millions of patients using GLP-1 drugs for weight loss could see costs skyrocket.
PBM rules dropped from Senate passed version of Trump's Bill
The policy would have prevented PBMs from having their compensation linked to the list prices of medications.
Mark Ratner joins AAM to lead Government Relations
Ratner will lead AAM’s government relations team across federal and state relations, advocacy, and alliances.
Kroger Health expands relationship to enhance patient care and access
The agreement with Centene will include pharmacist-led initiatives such as medication optimization, which can lead to improved quality of care and outcomes.
Big pharma prepares for next patent cliff as blockbuster drugs revenue losses loom, says GlobalData
According to GlobalData’s latest report, “Blockbuster Drugs on Patent Cliffs,” there is set to be a smaller proportion of global drug sales which will have patent protection in 2030, a sharp drop compared to previous years.
WeightWatchers and Novo Nordisk expand partnership
WeightWatchers clinic members can access FDAapproved Wegovy for $299 in July.